Drugs Made In America Acquisition II Corp. (DMIIU) Total Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Total Liabilities of $17.8 million for Q4 2025, up 6886.68% year-over-year from $254783.0 in Q4 2024, and down 2.07% quarter-over-quarter from $18.2 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Total Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Total Liabilities for 2 consecutive years, with $17.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities rose 6886.68% year-over-year to $17.8 million; the TTM figure through Dec 2025 stood at $17.8 million (up 6886.68% YoY), while the FY2025 annual figure was $17.8 million, up 6886.68% from the prior year.
- Total Liabilities declined to $17.8 million in Q4 2025 per DMIIU's latest filing, from $18.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $18.2 million in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.80 Mn |
| Sep 30, 2025 | 18.18 Mn |
| Dec 31, 2024 | 254,783.00 |